Industry News
Australian biotech market watch 28/09/09
Clinuvel Pharmaceuticals, Cellistis Limited, Acrux, CSL Limited [ + ]
Feature: Big questions about obesity
Obesity is more than just a psychological problem. Researchers like Mark Febbraio are serious about understanding more about the biology underlying obesity. [ + ]
Dionex to purchase ESA Biosciences’ HPLC portfolio
Dionex's purchase of ESA Biosciences' HPLC-related products will consolidate the company as a leading player in electrochemistry solutions for liquid chromatography.
[ + ]Evolution sheds light on breast cancer
Missense mutations in the ATM gene associated with breast cancer risk. [ + ]
Global patent application backlog passes 4.2 million
The current backlog of patent applications has passed 4.2 million and is growing unsustainably.
[ + ]Building a complete metabolic model
Scientists have developed a comprehensive model of the metabolic network overlaid with an atomic resolution of network proteins of Thermotoga maritim.
[ + ]Trial failures a setback to stem cell therapies
Two recent failed clinical trials have dealt a blow to stem cell research. [ + ]
Feature: Targeting leukaemia
Australian-US pharmaceutical company, ChemGenex, is close to bringing a new targeted drug to market, with implications for chronic myelogenous leukaemia and other blood-borne cancers. [ + ]
Product Wars: Survival gadgets
If the Tom Hanks movie Cast Away is anything to go by, being marooned on a deserted island is not much fun. [ + ]
NCRIS rolls out upgraded biotech labs
UNSW and Macquarie open upgraded labs for CV, cancer and biofuels research. [ + ]
Feature: Untying the haplomics knot
Unravelling the haplotype could reveal heretofore unknown links between genes and diseases. Dr Malcolm Simons thinks he might have a solution to this epic challenge. [ + ]
Gene therapy cures colour blindness
Adult monkeys colour blind since birth given trichromatic vision. [ + ]
Australian scientist launches authorship management system
A Brisbane-based researcher has launched an effective authorship management system that promises to reduce conflict for researchers during their careers.
[ + ]
